Previous 10 | Next 10 |
Summary We are downgrading SIGA to a sell rating because of the continued decline in the number of monkeypox cases in the US and the lukewarm retail interest in monkeypox. The lack of a near-term catalyst further complicates the investment case around SIGA. Because monkeypox spreads...
SIGA Technologies, Inc. (SIGA) Q3 2022 Results Conference Call November 03, 2022 04:30 PM ET Company Participants Phil Gomez - CEO Dan Luckshire - CFO Conference Call Participants Ken Mestemacher - Edison Brian Adams - Carter, Terry & Company ...
SIGA Technologies press release ( NASDAQ: SIGA ): Q3 GAAP EPS of $0.45. Revenue of $72.21M (+1404.4% Y/Y). For further details see: SIGA Technologies GAAP EPS of $0.45, revenue of $72.21M
- Approximately $61 Million of International Sales in the Third Quarter – - Corpor ate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceut...
An expert panel of the World Health Organization (WHO) has agreed to keep the emergency designation for the ongoing monkeypox outbreak, the global body announced on Tuesday. In July, WHO called the multi-country outbreak a public health emergency of international concern (PHEIC), ai...
NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, November 3 ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After becoming very popular with retail investors on social media, Revlon (NYSE: REV ) stock will be delisted soon . The cosmetics company declared bankruptcy in June, citing its huge debt and supply-chain issues. ...
Trials are currently underway in the United States, United Kingdom and Democratic Republic of Congo Pending positive results from clinical trials, SIGA plans to file with U.S. regulators for regulatory review of a TPOXX expanded indication for treatment of monkeypox NE...
SIGA Technologies (NASDAQ: SIGA) , a pharmaceutical company that specializes in health security countermeasures against biological, chemical, radiological, and nuclear attacks, along with vaccines and therapies to treat emerging infectious diseases, saw its shares fall 31.7% in Sept...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Postmodern Studio / Shutterstock.com Lordstown Motors (NASDAQ: RIDE ) stock is sliding lower on Thursday even after announcing commercial production of its Endurance pickup truck. Production of the ele...
News, Short Squeeze, Breakout and More Instantly...
SIGA Technologies Inc. Company Name:
SIGA Stock Symbol:
NASDAQ Market:
SIGA Technologies Inc. Website:
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised a procurement option for the delivery of approximately $113 million of or...
2024-06-26 21:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global health and infectious diseases, announced today an agreement to expand access to TPOXX (tecovirimat) to the member states in the Association of Southeast Asian Nations ...